Jason WilliamsPosted May 17, 2024
A brand-new disruptive asset class about to hit the scene called NatGold. And thanks to an obscure 19th-century law, this new investment is about to explode onto the scene, right here in the United...
Jason WilliamsPosted May 16, 2024
Former Morgan Stanley analyst, Jason Williams has been pounding the table about the top AI stocks to watch for BIG profits.
Jason SimpkinsPosted May 14, 2024
Look, I think we can all agree that the oil industry has been good to Exxon Mobil (NYSE: XOM). But there are some downsides to the business, too.
Alexander BouldenPosted May 13, 2024
After a decade of floundering, it looks like graphene is finally making good on those promises as a wonder material. The most exciting application for the near future is in next-generation...
Jason SimpkinsPosted May 11, 2024
IBM (NYSE: IBM) stock has shed about 10% of its value since the company reported earnings on April 24. That’s a big hit for a tech titan with a $153 billion market cap.
Jason WilliamsPosted May 10, 2024
Former Wall Street analyst, Jason Williams is convinced the AI goldrush is just getting started and he’s got a short list of the top unknown AI stocks to watch (and buy) for the next wave of AI...
Ben BroadwaterPosted May 9, 2024
Small-cap AI stocks offer investors the chance to capitalize on growth at an earlier stage, though they come with inherent risks due to their size and volatility.
Jason WilliamsPosted May 9, 2024
Later this month, Jason Williams will sit down with the CEO of Trump Media and Technology Group to discuss his plans to grow Trump Media stocks' share price.
Ben BroadwaterPosted May 8, 2024
In this article, we will break down the key elements of a stock market winning strategy to help you achieve your financial goals.
Alexander BouldenPosted May 8, 2024
It doesn’t always take a lot of money to make a lot in return. That’s why today we’re looking at the best dividend stocks under $20...
Jason SimpkinsPosted May 7, 2024
The bloated federal bureaucracy is now spilling revenue directly into the pockets of investors who are now taking in quarterly payouts to the tune of $7,882.
Alexander BouldenPosted May 6, 2024
In a historic move last week, the U.S. Drug Enforcement Agency revealed a proposal to reschedule cannabis from Schedule I to Schedule III.